NMYSF yields 11.96% · JNJ yields 2.14%● Live data
📍 NMYSF pulled ahead of the other in Year 1
Combined, NMYSF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NMYSF + JNJ for your $10,000?
NamSys Inc. provides software solutions for currency management and processing for the banking and merchant industries principally in North America. The company offers Cirreon Smart Safe, a cloud-based digital platform for managing networks of smart safes; Cash in Transit Logistics that manages routes, scans barcodes, and captures signatures digitally; and Deposit Tracking for tracking digital deposit data and transmits real-time updates. It also provides Online Change Orders for simplifying the change order process; and Currency Controller, a cash vault management and logistics system. It serves financial institutions, cash-in-transit industry, and banks and armored carriers. The company was formerly known as Cencotech Inc. and changed its name to NamSys Inc. in November 2016. NamSys Inc. was incorporated in 1997 and is headquartered in Toronto, Canada.
Full NMYSF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.